HER2 Support Group Forums - Tigris Pharmaceuticals Initiates Randomized Phase 2 Study Of AFP-464 In ER-Positive B

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - Tigris Pharmaceuticals Initiates Randomized Phase 2 Study Of AFP-464 In ER-Positive B (https://her2support.org/vbulletin/showthread.php?t=50173)

News	05-27-2011 01:06 AM

Tigris Pharmaceuticals Initiates Randomized Phase 2 Study Of AFP-464 In ER-Positive B

Tigris Pharmaceuticals, Inc., announced enrollment of its first patient in a randomized Phase 2 clinical trial of AFP-464 (aminoflavone prodrug) with or without Faslodex® (fulvestrant) in estrogen receptor (ER)-positive breast cancer patients...

More...

All times are GMT -7. The time now is 06:04 AM.